Your browser doesn't support javascript.
loading
Clinical pharmacogenetics implementation consortium guidelines for CYP2C9 and HLA-B genotypes and phenytoin dosing.
Caudle, K E; Rettie, A E; Whirl-Carrillo, M; Smith, L H; Mintzer, S; Lee, M T M; Klein, T E; Callaghan, J T.
Afiliação
  • Caudle KE; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Rettie AE; Department of Medicinal Chemistry, University of Washington School of Pharmacy, Seattle, Washington, USA.
  • Whirl-Carrillo M; Department of Genetics, Stanford University, Palo Alto, California, USA.
  • Smith LH; Division of Pediatric Neurology, Department of Neurology, Indiana University, Indianapolis, Indiana, USA.
  • Mintzer S; Department of Neurology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Lee MT; 1] Laboratory for International Alliance on Genomic Research, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan [2] National Center for Genome Medicine, Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan [3] School of Chinese Medicine, China Medical University, Taichung,
  • Klein TE; Department of Genetics, Stanford University, Palo Alto, California, USA.
  • Callaghan JT; 1] Division of Clinical Pharmacology, Department of Medicines, Indiana University School of Medicine and Pharmacology/Toxicology, Indianapolis, Indiana, USA [2] Department of Veterans Affairs, RLR VA Medical Center, Indianapolis, Indiana, USA.
Clin Pharmacol Ther ; 96(5): 542-8, 2014 Nov.
Article em En | MEDLINE | ID: mdl-25099164
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fenitoína / Antígenos HLA-B / Citocromo P-450 CYP2C9 / Anticonvulsivantes Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: Clin Pharmacol Ther Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fenitoína / Antígenos HLA-B / Citocromo P-450 CYP2C9 / Anticonvulsivantes Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: Clin Pharmacol Ther Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Estados Unidos